REGENERON PHARMACEUTICALS earnings per share and revenue

4REGN earnings per share for the last quarter are 11.19 EUR whereas the estimation was 10.50 EUR which accounts for 6.54% surprise. Company revenue for the same period amounts to 3.34 B EUR despite the estimated figure of 3.30 B EUR. Estimated earnings per share for the next quarter are 10.45 EUR, and revenue is expected to reach 3.50 B EUR. Also watch annual changes over time to get a bigger picture of 4REGN earnings per share and revenue dynamics.